Coronary Plaque Features on CTA Can Identify Patients at Increased Risk of Cardiovascular Events.


Journal

JACC. Cardiovascular imaging
ISSN: 1876-7591
Titre abrégé: JACC Cardiovasc Imaging
Pays: United States
ID NLM: 101467978

Informations de publication

Date de publication:
08 2020
Historique:
received: 21 11 2018
revised: 10 06 2019
accepted: 17 06 2019
pubmed: 20 8 2019
medline: 22 7 2021
entrez: 19 8 2019
Statut: ppublish

Résumé

This study sought to assess whether coronary atherosclerosis analysis by coronary computed tomography angiography (CTA) may improve prognostic stratification among patients with diffuse coronary artery disease (CAD) BACKGROUND: Coronary CTA has recently emerged as a promising noninvasive tool for advanced analysis of coronary atherosclerosis. The multicenter CAPIRE (Coronary Atherosclerosis in outlier subjects: Protective and novel Individual Risk factors Evaluation) study is part of the GISSI Outlier Project. A prospective cohort of subjects who underwent coronary CTA for suspected CAD was enrolled. Based on risk factor (RF) burden, patients were defined as having a low clinical risk (0 to 1 RF with the exclusion of patients with diabetes mellitus as single RF) or at high clinical risk (3 or more RFs). Patients with 2 RFs were not enrolled in the study. Coronary CTA advanced plaque assessment was performed. Outcome measures were 3 combined endpoints: acute coronary syndrome (ACS), cardiac death + ACS, and cardiac death + ACS + late revascularization. Among the 544 patients enrolled in the CAPIRE study, in 522 patients, a mean follow-up of 37 ± 10 months was obtained (16 patients were excluded due to 1 < segment involvement score <5 at core lab coronary CTA analysis and 6 patients were lost at follow-up). Higher atherosclerotic burden was found in patients with higher clinical risk, but prevalence of elevated noncalcified plaque volume did not significantly differ between low- versus high-risk patients. Quantitative plaque parameters by coronary CTA were associated with composite endpoints at multivariable analysis when corrected for univariate predictors. Elevated noncalcified plaque volume, expressed as dichotomic variable, was associated with all combined endpoints. Even if the low absolute number of events represents a limitation to the present study, patients with low noncalcified plaque volume had similar risk of cardiac events independently from the presence of multivessel disease, while patients with high noncalcified plaque volume had higher rates of cardiac events. The CAPIRE study confirmed the prognostic value of atherosclerosis assessment by coronary CTA, demonstrating high noncalcified plaque volume as the most ACS-predictive parameter in patients with extensive CAD. (GISSE Outliers CAPIRE [CAPIRE]; NCT02157662).

Identifiants

pubmed: 31422137
pii: S1936-878X(19)30611-4
doi: 10.1016/j.jcmg.2019.06.019
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02157662']

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1704-1717

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Auteurs

Daniele Andreini (D)

Centro Cardiologico Monzino, Institute for Research, Hospitalization and Health Care, Milan, Italy; Department of Clinical Sciences and Community Health, Cardiovascular Section, University of Milan, Milan, Italy. Electronic address: daniele.andreini@ccfm.it.

Marco Magnoni (M)

Heart Care Foundation Onlus, Florence, Italy.

Edoardo Conte (E)

Centro Cardiologico Monzino, Institute for Research, Hospitalization and Health Care, Milan, Italy.

Serge Masson (S)

Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche "Mario Negri," Institute for Research, Hospitalization and Health Care, Milan, Italy.

Saima Mushtaq (S)

Centro Cardiologico Monzino, Institute for Research, Hospitalization and Health Care, Milan, Italy.

Sergio Berti (S)

UO Adult Cardiology, Stabilimento di Massa, Fondazione Toscana G. Monasterio per la Ricerca Medica e di Sanità, Massa, Italy.

Mauro Canestrari (M)

Department of Cardiology, Santa Croce Hospital, Fano, Italy.

Giancarlo Casolo (G)

Department of Cardiology, Nuovo Ospedale Versilia, Lido di Camaiore, Italy.

Domenico Gabrielli (D)

Department of Cardiology, Ospedale Civile A. Murri, Fermo, Italy.

Roberto Latini (R)

Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche "Mario Negri," Institute for Research, Hospitalization and Health Care, Milan, Italy.

Paolo Marraccini (P)

Clinical Psychology Institute, Consiglio Nazionale delle Richerche, Fondazione Toscana G. Monasterio, S.A. Emodinamica, Pisa, Italy.

Tiziano Moccetti (T)

Cardiovasclar Research Service, Cardiocentro Ticino, Lugano, Switzerland.

Maria Grazia Modena (MG)

Department of Cardiology, Ospedale Policlinico, Modena, Italy.

Gianluca Pontone (G)

Centro Cardiologico Monzino, Institute for Research, Hospitalization and Health Care, Milan, Italy.

Marco Gorini (M)

ANMCO Research Center, Heart Care Foundation Onlus, Florence, Italy.

Aldo P Maggioni (AP)

ANMCO Research Center, Heart Care Foundation Onlus, Florence, Italy.

Attilio Maseri (A)

Heart Care Foundation Onlus, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH